Product NDC: | 0310-0951 |
Proprietary Name: | ZOLADEX |
Non Proprietary Name: | Goserelin acetate |
Active Ingredient(s): | 10.8 mg/1 & nbsp; Goserelin acetate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | IMPLANT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0310-0951 |
Labeler Name: | AstraZeneca Pharmaceuticals LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020578 |
Marketing Category: | NDA |
Start Marketing Date: | 20030505 |
Package NDC: | 0310-0951-30 |
Package Description: | 1 POUCH in 1 CARTON (0310-0951-30) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE |
NDC Code | 0310-0951-30 |
Proprietary Name | ZOLADEX |
Package Description | 1 POUCH in 1 CARTON (0310-0951-30) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE |
Product NDC | 0310-0951 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Goserelin acetate |
Dosage Form Name | IMPLANT |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20030505 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | GOSERELIN ACETATE |
Strength Number | 10.8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] |